This article is part of the supplement: Proceedings of the 2009 Drug Discovery for Neurodegeneration Conference
Proceedings
Characteristics of compounds that cross the blood-brain barrier
BMC Neurology 2009, 9(Suppl 1):S3 doi:10.1186/1471-2377-9-S1-S3
No comments have yet been made on this article.
